Next Quarterly Earnings
Thursday, July 23, 2026
CW 30
Pre-Market
In 10 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
argenx ADR
argenx ADR is a Dutch biotechnology company developing innovative antibody-based medicines for severe autoimmune diseases and rare diseases. Through advanced clinical research, argenx ADR offers new therapeutic options to improve the lives of patients globally. The pipeline focuses on pioneering therapies.
Frequently asked questions
When will argenx ADR report its next quarterly earnings?
argenx ADR is scheduled to report its next quarterly earnings on 07/23/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did argenx ADR last report quarterly earnings?
argenx ADR last reported quarterly earnings on 5/7/2026 (Q2 2026). Earnings per share (EPS) came in at 5.52 USD.
How does argenx ADR stock react to earnings?
Across its last 3 earnings reports, argenx ADR stock moved by ±2.8% on average the following day. The largest reaction was -5.6% on 02/26/2026; 0 of 3 reactions were positive.
How often has argenx ADR beaten expectations?
argenx ADR has beaten analyst EPS estimates in 4 of its last 4 evaluated quarters (beat rate: 100%).
How do I add the argenx ADR earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±2.8%
Avg. next-day move
-5.6%
Largest move (02/26/2026)
0%
Share of positive reactions
±5.4%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
4/4
Quarters above estimates
100%
Beat rate
+9.5%
Avg. EPS surprise
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
argenx ADR
Country
🇳🇱
More Financial Information